Oregon Public Employees Retirement Fund Cara Therapeutics, Inc. Transaction History

Oregon Public Employees Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$4.89 - $12.27 $195 - $490	-40 Reduced 0.27%	14,910 $73,000
Q4 2022 Jan 26, 2023	SELL	$8.88 - $12.77 $230 - $332	-26 Reduced 0.17%	14,950 $0
Q3 2022 Nov 01, 2022	BUY	$8.24 - $12.56 $8,915 - $13,589	1,082 Added 7.79%	14,976 $140,000
Q2 2022 Jul 25, 2022	SELL	$7.45 - $13.84 $17,880 - $33,216	-2,400 Reduced 14.73%	13,894 $127,000
Q1 2022 Apr 21, 2022	SELL	$9.94 - $12.65 $2,982 - $3,795	-300 Reduced 1.81%	16,294 $198,000
Q4 2021 Feb 01, 2022	SELL	$11.99 - $18.14 $9,592 - $14,512	-800 Reduced 4.6%	16,594 $202,000
Q3 2021 Oct 19, 2021	SELL	$11.55 - $16.06 $1,155 - $1,605	-100 Reduced 0.57%	17,394 $269,000
Q2 2021 Jul 23, 2021	BUY	$12.38 - $29.19 $216,575 - $510,649	17,494 New	17,494 $250,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.